Limits...
Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.

Thomas GJ, Hart IR, Speight PM, Marshall JF - Br. J. Cancer (2002)

Bottom Line: Since TGF-beta1 is present in squamous carcinomas, it is possible that latency associated peptide may modulate malignant keratinocyte behaviour independently from the classical TGF-beta signalling pathways through its interaction with integrins.We show here that when latency associated peptide is immobilised onto a surface, it acts as an alpha(v)beta6-specific ligand for oral squamous carcinoma cells promoting adhesion and haptotactic migration in addition to alpha(v)beta6-dependent increase in pro-MMP-9 expression.In contrast, even very low concentrations of soluble latency associated peptide (0.1 microg ml(-1)) inhibited alpha(v)beta6-dependent adhesion, migration and invasion.

View Article: PubMed Central - PubMed

Affiliation: Department of Oral Pathology, Eastman Dental Institute, University College London, UK.

Show MeSH

Related in: MedlinePlus

Soluble LAP inhibits αvβ6 interaction with fibronectin. (A) LAP inhibits VB6 adhesion to fibronectin. Chromium [51Cr]-labelled VB6 cells were added to fibronectin-coated 96-well plates containing an irrelevant control antibody (W632) or test antibodies against αvβ6 (10D5), α5β1 (P1D6) and LAP (0.25 μg ml−1) or combinations thereof. Figure shows a representative experiment performed in quadruplicate. Results are expressed relative to binding in the presence of a control antibody (=100). Background binding to BSA has been subtracted from the results. Error bars represent standard deviation. VB6 cells adhere to fibronectin through αvβ6 and α5β1 and a combination of antibodies against both integrins is required to block adhesion completely (Thomas et al, 2001b). Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion significantly (neither did a combination of LAP and anti-αvβ6). However, combinations of anti-α5β1 and LAP or anti-αvβ6 and anti-α5β1 inhibited adhesion completely. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggests that LAP may alter keratinocyte binding to fibronectin through its interaction with the αvβ6 integrin. (B) LAP inhibits VB6 migration to fibronectin. To determine the effect of LAP on cell migration, the cells were treated with varying concentrations of LAP peptide prior to plating and then allowed to migrate for 8 h before counting. A representative experiment performed in quadruplicate is shown. Results are expressed relative to migration in the presence of a control antibody (=100). Error bars represent standard deviation. Haptotactic migration of VB6 cells towards fibronectin is modulated through αvβ6 and α5β1 integrins and maximal inhibition of migration is produced by blocking both integrins (Thomas et al, 2001b). Migration of VB6 cells towards fibronectin was inhibited by a concentration of LAP as low as 0.1 μg ml−1 (51% inhibition). At higher concentrations a further degree of inhibition was seen (0.25 μg ml−1=63% inhibition). This level of inhibition was similar to that produced by anti-αvβ6 antibody (54% inhibition) and did not differ significantly from a combination of LAP and anti-αvβ6 antibody (52% inhibition). Complete inhibition of migration was produced using a combination of soluble LAP with anti-α5β1 antibody (or a combination of anti-αvβ6 with anti-α5β1 antibody). Soluble LAP had no effect of the migration of H357 αv-negative cells. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggest that LAP may inhibit αvβ6-dependent keratinocyte migration towards fibronectin. (C) LAP inhibits αvβ6-dependent invasion through Matrigel. Cell invasion assays were performed over 72 h using Matrigel coated polycarbonate filters. To assess the effect of soluble LAP invasion, cells were treated with LAP (0.5 μg ml−1) for 30 min at 4°C prior to plating. Following incubation the cells in the lower chamber (including those attached to the undersurface of the membrane) were trypsinised and counted on a Casy 1 counter (Sharfe System GmbH, Germany). Figure shows a representative experiment performed in quadruplicate. Error bars represent standard deviation. Pre-incubation of VB6 cells with soluble LAP inhibited invasion (62% inhibition), producing a similar level of inhibition to anti-αvβ6 antibody (58% inhibition). Soluble LAP had no effect on invasion of H357 αv-negative cells or C1 control cells which express low levels of endogenous αvβ6. These data suggest that soluble LAP may inhibit αvβ6-dependent cell invasion.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2376166&req=5

fig5: Soluble LAP inhibits αvβ6 interaction with fibronectin. (A) LAP inhibits VB6 adhesion to fibronectin. Chromium [51Cr]-labelled VB6 cells were added to fibronectin-coated 96-well plates containing an irrelevant control antibody (W632) or test antibodies against αvβ6 (10D5), α5β1 (P1D6) and LAP (0.25 μg ml−1) or combinations thereof. Figure shows a representative experiment performed in quadruplicate. Results are expressed relative to binding in the presence of a control antibody (=100). Background binding to BSA has been subtracted from the results. Error bars represent standard deviation. VB6 cells adhere to fibronectin through αvβ6 and α5β1 and a combination of antibodies against both integrins is required to block adhesion completely (Thomas et al, 2001b). Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion significantly (neither did a combination of LAP and anti-αvβ6). However, combinations of anti-α5β1 and LAP or anti-αvβ6 and anti-α5β1 inhibited adhesion completely. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggests that LAP may alter keratinocyte binding to fibronectin through its interaction with the αvβ6 integrin. (B) LAP inhibits VB6 migration to fibronectin. To determine the effect of LAP on cell migration, the cells were treated with varying concentrations of LAP peptide prior to plating and then allowed to migrate for 8 h before counting. A representative experiment performed in quadruplicate is shown. Results are expressed relative to migration in the presence of a control antibody (=100). Error bars represent standard deviation. Haptotactic migration of VB6 cells towards fibronectin is modulated through αvβ6 and α5β1 integrins and maximal inhibition of migration is produced by blocking both integrins (Thomas et al, 2001b). Migration of VB6 cells towards fibronectin was inhibited by a concentration of LAP as low as 0.1 μg ml−1 (51% inhibition). At higher concentrations a further degree of inhibition was seen (0.25 μg ml−1=63% inhibition). This level of inhibition was similar to that produced by anti-αvβ6 antibody (54% inhibition) and did not differ significantly from a combination of LAP and anti-αvβ6 antibody (52% inhibition). Complete inhibition of migration was produced using a combination of soluble LAP with anti-α5β1 antibody (or a combination of anti-αvβ6 with anti-α5β1 antibody). Soluble LAP had no effect of the migration of H357 αv-negative cells. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggest that LAP may inhibit αvβ6-dependent keratinocyte migration towards fibronectin. (C) LAP inhibits αvβ6-dependent invasion through Matrigel. Cell invasion assays were performed over 72 h using Matrigel coated polycarbonate filters. To assess the effect of soluble LAP invasion, cells were treated with LAP (0.5 μg ml−1) for 30 min at 4°C prior to plating. Following incubation the cells in the lower chamber (including those attached to the undersurface of the membrane) were trypsinised and counted on a Casy 1 counter (Sharfe System GmbH, Germany). Figure shows a representative experiment performed in quadruplicate. Error bars represent standard deviation. Pre-incubation of VB6 cells with soluble LAP inhibited invasion (62% inhibition), producing a similar level of inhibition to anti-αvβ6 antibody (58% inhibition). Soluble LAP had no effect on invasion of H357 αv-negative cells or C1 control cells which express low levels of endogenous αvβ6. These data suggest that soluble LAP may inhibit αvβ6-dependent cell invasion.

Mentions: VB6 cells bind to fibronectin through both αvβ6 and α5β1 integrins such that to completely inhibit adhesion to this substrate, a combination of blocking antibodies against both integrins is required (Thomas et al, 2001b). To determine whether LAP competitively inhibits αvβ6-dependent binding to fibronectin, VB6 cells were incubated with LAP (0.25 μg ml−1) or antibodies against αvβ6 (10D5) or α5β1 (P1D6) prior to plating. Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion to fibronectin significantly (Figure 5AFigure 5


Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.

Thomas GJ, Hart IR, Speight PM, Marshall JF - Br. J. Cancer (2002)

Soluble LAP inhibits αvβ6 interaction with fibronectin. (A) LAP inhibits VB6 adhesion to fibronectin. Chromium [51Cr]-labelled VB6 cells were added to fibronectin-coated 96-well plates containing an irrelevant control antibody (W632) or test antibodies against αvβ6 (10D5), α5β1 (P1D6) and LAP (0.25 μg ml−1) or combinations thereof. Figure shows a representative experiment performed in quadruplicate. Results are expressed relative to binding in the presence of a control antibody (=100). Background binding to BSA has been subtracted from the results. Error bars represent standard deviation. VB6 cells adhere to fibronectin through αvβ6 and α5β1 and a combination of antibodies against both integrins is required to block adhesion completely (Thomas et al, 2001b). Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion significantly (neither did a combination of LAP and anti-αvβ6). However, combinations of anti-α5β1 and LAP or anti-αvβ6 and anti-α5β1 inhibited adhesion completely. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggests that LAP may alter keratinocyte binding to fibronectin through its interaction with the αvβ6 integrin. (B) LAP inhibits VB6 migration to fibronectin. To determine the effect of LAP on cell migration, the cells were treated with varying concentrations of LAP peptide prior to plating and then allowed to migrate for 8 h before counting. A representative experiment performed in quadruplicate is shown. Results are expressed relative to migration in the presence of a control antibody (=100). Error bars represent standard deviation. Haptotactic migration of VB6 cells towards fibronectin is modulated through αvβ6 and α5β1 integrins and maximal inhibition of migration is produced by blocking both integrins (Thomas et al, 2001b). Migration of VB6 cells towards fibronectin was inhibited by a concentration of LAP as low as 0.1 μg ml−1 (51% inhibition). At higher concentrations a further degree of inhibition was seen (0.25 μg ml−1=63% inhibition). This level of inhibition was similar to that produced by anti-αvβ6 antibody (54% inhibition) and did not differ significantly from a combination of LAP and anti-αvβ6 antibody (52% inhibition). Complete inhibition of migration was produced using a combination of soluble LAP with anti-α5β1 antibody (or a combination of anti-αvβ6 with anti-α5β1 antibody). Soluble LAP had no effect of the migration of H357 αv-negative cells. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggest that LAP may inhibit αvβ6-dependent keratinocyte migration towards fibronectin. (C) LAP inhibits αvβ6-dependent invasion through Matrigel. Cell invasion assays were performed over 72 h using Matrigel coated polycarbonate filters. To assess the effect of soluble LAP invasion, cells were treated with LAP (0.5 μg ml−1) for 30 min at 4°C prior to plating. Following incubation the cells in the lower chamber (including those attached to the undersurface of the membrane) were trypsinised and counted on a Casy 1 counter (Sharfe System GmbH, Germany). Figure shows a representative experiment performed in quadruplicate. Error bars represent standard deviation. Pre-incubation of VB6 cells with soluble LAP inhibited invasion (62% inhibition), producing a similar level of inhibition to anti-αvβ6 antibody (58% inhibition). Soluble LAP had no effect on invasion of H357 αv-negative cells or C1 control cells which express low levels of endogenous αvβ6. These data suggest that soluble LAP may inhibit αvβ6-dependent cell invasion.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2376166&req=5

fig5: Soluble LAP inhibits αvβ6 interaction with fibronectin. (A) LAP inhibits VB6 adhesion to fibronectin. Chromium [51Cr]-labelled VB6 cells were added to fibronectin-coated 96-well plates containing an irrelevant control antibody (W632) or test antibodies against αvβ6 (10D5), α5β1 (P1D6) and LAP (0.25 μg ml−1) or combinations thereof. Figure shows a representative experiment performed in quadruplicate. Results are expressed relative to binding in the presence of a control antibody (=100). Background binding to BSA has been subtracted from the results. Error bars represent standard deviation. VB6 cells adhere to fibronectin through αvβ6 and α5β1 and a combination of antibodies against both integrins is required to block adhesion completely (Thomas et al, 2001b). Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion significantly (neither did a combination of LAP and anti-αvβ6). However, combinations of anti-α5β1 and LAP or anti-αvβ6 and anti-α5β1 inhibited adhesion completely. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggests that LAP may alter keratinocyte binding to fibronectin through its interaction with the αvβ6 integrin. (B) LAP inhibits VB6 migration to fibronectin. To determine the effect of LAP on cell migration, the cells were treated with varying concentrations of LAP peptide prior to plating and then allowed to migrate for 8 h before counting. A representative experiment performed in quadruplicate is shown. Results are expressed relative to migration in the presence of a control antibody (=100). Error bars represent standard deviation. Haptotactic migration of VB6 cells towards fibronectin is modulated through αvβ6 and α5β1 integrins and maximal inhibition of migration is produced by blocking both integrins (Thomas et al, 2001b). Migration of VB6 cells towards fibronectin was inhibited by a concentration of LAP as low as 0.1 μg ml−1 (51% inhibition). At higher concentrations a further degree of inhibition was seen (0.25 μg ml−1=63% inhibition). This level of inhibition was similar to that produced by anti-αvβ6 antibody (54% inhibition) and did not differ significantly from a combination of LAP and anti-αvβ6 antibody (52% inhibition). Complete inhibition of migration was produced using a combination of soluble LAP with anti-α5β1 antibody (or a combination of anti-αvβ6 with anti-α5β1 antibody). Soluble LAP had no effect of the migration of H357 αv-negative cells. These data confirm that soluble LAP produces a similar effect to anti-αvβ6 antibody and suggest that LAP may inhibit αvβ6-dependent keratinocyte migration towards fibronectin. (C) LAP inhibits αvβ6-dependent invasion through Matrigel. Cell invasion assays were performed over 72 h using Matrigel coated polycarbonate filters. To assess the effect of soluble LAP invasion, cells were treated with LAP (0.5 μg ml−1) for 30 min at 4°C prior to plating. Following incubation the cells in the lower chamber (including those attached to the undersurface of the membrane) were trypsinised and counted on a Casy 1 counter (Sharfe System GmbH, Germany). Figure shows a representative experiment performed in quadruplicate. Error bars represent standard deviation. Pre-incubation of VB6 cells with soluble LAP inhibited invasion (62% inhibition), producing a similar level of inhibition to anti-αvβ6 antibody (58% inhibition). Soluble LAP had no effect on invasion of H357 αv-negative cells or C1 control cells which express low levels of endogenous αvβ6. These data suggest that soluble LAP may inhibit αvβ6-dependent cell invasion.
Mentions: VB6 cells bind to fibronectin through both αvβ6 and α5β1 integrins such that to completely inhibit adhesion to this substrate, a combination of blocking antibodies against both integrins is required (Thomas et al, 2001b). To determine whether LAP competitively inhibits αvβ6-dependent binding to fibronectin, VB6 cells were incubated with LAP (0.25 μg ml−1) or antibodies against αvβ6 (10D5) or α5β1 (P1D6) prior to plating. Treating the cells solely with LAP, or antibodies against αvβ6 or α5β1 did not inhibit adhesion to fibronectin significantly (Figure 5AFigure 5

Bottom Line: Since TGF-beta1 is present in squamous carcinomas, it is possible that latency associated peptide may modulate malignant keratinocyte behaviour independently from the classical TGF-beta signalling pathways through its interaction with integrins.We show here that when latency associated peptide is immobilised onto a surface, it acts as an alpha(v)beta6-specific ligand for oral squamous carcinoma cells promoting adhesion and haptotactic migration in addition to alpha(v)beta6-dependent increase in pro-MMP-9 expression.In contrast, even very low concentrations of soluble latency associated peptide (0.1 microg ml(-1)) inhibited alpha(v)beta6-dependent adhesion, migration and invasion.

View Article: PubMed Central - PubMed

Affiliation: Department of Oral Pathology, Eastman Dental Institute, University College London, UK.

Show MeSH
Related in: MedlinePlus